Overview
Qilai Long practices in Zhongshan, China. Long is rated as an Experienced expert by MediFind in the treatment of Angiomyoma. Their top areas of expertise are Renal Cell Carcinoma (RCC), Angiomyoma, Bladder Cancer, Lithotripsy, and Nephrectomy.
Their clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Angiomyoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AngiomyomaLong isExperienced. Learn about Angiomyoma.
- Bladder CancerLong isExperienced. Learn about Bladder Cancer.
- LithotripsyLong isExperienced. Learn about Lithotripsy.
- NecrosisLong isExperienced. Learn about Necrosis.
- NephrectomyLong isExperienced. Learn about Nephrectomy.
- Renal Cell Carcinoma (RCC)Long isExperienced. Learn about Renal Cell Carcinoma (RCC).